Endothelial progenitor cells and mesenchymal stem cells to overcome vascular deterioration and cytokine storm in critical patients with COVID-19

Med Hypotheses. 2020 Nov:144:109973. doi: 10.1016/j.mehy.2020.109973. Epub 2020 Jun 10.
No abstract available

Keywords: COVID-19; Endothelial progenitor cells; Mesenchymal stem cells.

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • COVID-19 / therapy*
  • COVID-19 Drug Treatment
  • Cell- and Tissue-Based Therapy*
  • Critical Illness
  • Cytokine Release Syndrome / virology*
  • Endothelial Progenitor Cells / cytology*
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Models, Theoretical
  • Pandemics

Substances

  • Anti-Inflammatory Agents